Literature DB >> 19193747

Technetium Tc99m-tetrofosmin brain single-photon emission CT for the diagnosis of malignant meningiomas.

G A Alexiou, S Voulgaris, S Tsiouris, A D Fotopoulos, A P Kyritsis, K S Polyzoidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19193747      PMCID： PMC7051383          DOI： 10.3174/ajnr.A1286

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  5 in total

1.  DNA ploidy and cell-cycle analysis in intracranial meningiomas and hemangiopericytomas: a study with high-resolution DNA flow cytometry.

Authors:  A Zellner; J Meixensberger; W Roggendorf; M Janka; H Hoehn; K Roosen
Journal:  Int J Cancer       Date:  1998-04-17       Impact factor: 7.396

2.  (99m)Tc-Tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index.

Authors:  Andreas D Fotopoulos; George A Alexiou; Ann Goussia; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Spyridon Voulgaris; Spyridon Tsiouris
Journal:  J Neurooncol       Date:  2008-05-06       Impact factor: 4.130

3.  Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation.

Authors:  V A Nagar; J R Ye; W H Ng; Y H Chan; F Hui; C K Lee; C C T Lim
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

4.  Evaluation of meningioma aggressiveness by (99m)Tc-Tetrofosmin SPECT.

Authors:  George A Alexiou; George Vartholomatos; Spyridon Tsiouris; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Spyridon Voulgaris; Andreas D Fotopoulos
Journal:  Clin Neurol Neurosurg       Date:  2008-05-08       Impact factor: 1.876

5.  Clinical and radiological features related to the growth potential of meningioma.

Authors:  Hidetoshi Kasuya; Osami Kubo; Masahiko Tanaka; Kosaku Amano; Koichi Kato; Tomokatsu Hori
Journal:  Neurosurg Rev       Date:  2006-09-05       Impact factor: 3.042
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.